Wholesaler Sues Sanofi-Aventis Over Arthritis Drug
A drug wholesaler has sought treble damages in a putative class action lawsuit against Sanofi-Aventis, accusing the French pharmaceutical giant of unlawfully blocking generic competition for Sanofi's rheumatoid arthritis treatment Arava...To view the full article, register now.
Already a subscriber? Click here to view full article